Logo image of EM

SMART SHARE GLOBAL LTD - ADR (EM) Stock Fundamental Analysis

USA - NASDAQ:EM - US83193E1029 - ADR

1.35 USD
-0.01 (-0.74%)
Last: 9/12/2025, 3:24:55 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EM. EM was compared to 123 industry peers in the Specialty Retail industry. The financial health of EM is average, but there are quite some concerns on its profitability. EM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EM had negative earnings in the past year.
EM had a negative operating cash flow in the past year.
In the past 5 years EM reported 4 times negative net income.
Of the past 5 years EM 4 years had a positive operating cash flow.
EM Yearly Net Income VS EBIT VS OCF VS FCFEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

EM has a Return On Assets (-0.36%) which is comparable to the rest of the industry.
EM has a Return On Equity (-0.56%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.36%
ROE -0.56%
ROIC N/A
ROA(3y)-4.97%
ROA(5y)-48.01%
ROE(3y)-8.06%
ROE(5y)-72.39%
ROIC(3y)N/A
ROIC(5y)N/A
EM Yearly ROA, ROE, ROICEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Gross Margin of EM (42.43%) is better than 65.04% of its industry peers.
In the last couple of years the Gross Margin of EM has declined.
EM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.53%
GM growth 5Y-13.1%
EM Yearly Profit, Operating, Gross MarginsEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100

5

2. Health

2.1 Basic Checks

EM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EM has less shares outstanding
EM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EM has a worse debt to assets ratio.
EM Yearly Shares OutstandingEM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EM Yearly Total Debt VS Total AssetsEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

EM has an Altman-Z score of -0.95. This is a bad value and indicates that EM is not financially healthy and even has some risk of bankruptcy.
EM has a Altman-Z score of -0.95. This is amonst the worse of the industry: EM underperforms 82.11% of its industry peers.
EM has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of EM (0.00) is better than 73.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.95
ROIC/WACCN/A
WACC8.31%
EM Yearly LT Debt VS Equity VS FCFEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 3.17 indicates that EM has no problem at all paying its short term obligations.
EM's Current ratio of 3.17 is amongst the best of the industry. EM outperforms 92.68% of its industry peers.
A Quick Ratio of 3.08 indicates that EM has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.08, EM belongs to the best of the industry, outperforming 96.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.17
Quick Ratio 3.08
EM Yearly Current Assets VS Current LiabilitesEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

The earnings per share for EM have decreased strongly by -110.53% in the last year.
EM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.95%.
The Revenue has been decreasing by -1.30% on average over the past years.
EPS 1Y (TTM)-110.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
Revenue 1Y (TTM)-35.95%
Revenue growth 3Y-19.16%
Revenue growth 5Y-1.3%
Sales Q2Q%11.79%

3.2 Future

The Earnings Per Share is expected to grow by 46.41% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.01% on average over the next years.
EPS Next Y96.62%
EPS Next 2Y46.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.76%
Revenue Next 2Y6.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EM Yearly Revenue VS EstimatesEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
EM Yearly EPS VS EstimatesEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5

3

4. Valuation

4.1 Price/Earnings Ratio

EM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 13.36, EM is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EM indicates a somewhat cheap valuation: EM is cheaper than 74.80% of the companies listed in the same industry.
EM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 13.36
EM Price Earnings VS Forward Price EarningsEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EM indicates a slightly more expensive valuation: EM is more expensive than 60.98% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.3
EM Per share dataEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

EM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EM's earnings are expected to grow with 46.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.41%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EM!.
Industry RankSector Rank
Dividend Yield N/A

SMART SHARE GLOBAL LTD - ADR

NASDAQ:EM (9/12/2025, 3:24:55 PM)

1.35

-0.01 (-0.74%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-18 2025-08-18
Earnings (Next)03-02 2026-03-02
Inst Owners10.22%
Inst Owner Change3.32%
Ins Owners2.23%
Ins Owner ChangeN/A
Market Cap342.36M
Analysts86.67
Price Target2.76 (104.44%)
Short Float %0.02%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DP-368.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)46.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.36
P/S 1.29
P/FCF N/A
P/OCF N/A
P/B 0.92
P/tB 0.92
EV/EBITDA 29.3
EPS(TTM)-0.01
EYN/A
EPS(NY)0.1
Fwd EY7.49%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS1.05
BVpS1.47
TBVpS1.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.36%
ROE -0.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.43%
FCFM N/A
ROA(3y)-4.97%
ROA(5y)-48.01%
ROE(3y)-8.06%
ROE(5y)-72.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.53%
GM growth 5Y-13.1%
F-Score2
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.01
Cap/Depr 5.96%
Cap/Sales 0.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.17
Quick Ratio 3.08
Altman-Z -0.95
F-Score2
WACC8.31%
ROIC/WACCN/A
Cap/Depr(3y)59.09%
Cap/Depr(5y)83.54%
Cap/Sales(3y)7.42%
Cap/Sales(5y)10.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-110.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
EPS Next Y96.62%
EPS Next 2Y46.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.95%
Revenue growth 3Y-19.16%
Revenue growth 5Y-1.3%
Sales Q2Q%11.79%
Revenue Next Year6.76%
Revenue Next 2Y6.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-856.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year306.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-192.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-149.52%
OCF growth 3YN/A
OCF growth 5YN/A